PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 15 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Compounds 3, 5, 6, and 9 reduced lipogenesis in HepG2 cells in a dose-dependent manner [PMID:35957573]
Chloramultilide B exhibited moderate in vitro antifungal activity [PMID:18044839]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35957573 (2022) — Spicatulides A-G, Phenolic-Monoterpenoid Hybrids from Chloranthus spicatus. · Journal of natural products
- 2.PMID: 41551821 (2026) — Effects of drying methods on volatile profiles of Chloranthus spicatus and quality of its scented tea: Chemometric approaches. · Food chemistry: X
- 3.PMID: 34836973 (2021) — Chloranthus genome provides insights into the early diversification of angiosperms. · Nature communications
- 4.PMID: 18044839 (2007) — Mono- and Di-sesquiterpenoids from Chloranthus spicatus. · Journal of natural products
- 5.PMID: 37645629 (2023) — Comparison analysis of full-spectrum metabolomics revealed on the variation of potential metabolites of unscented, Chloranthus spicatus scented, and Osmanthus fragrans (Thunb.) Lour. scented Congou black teas.